P3.03-019 Activity of PARP Inhibitor in NSCLC with Germline and Somatic Mutation and in Silico Chemotherapy LethalityCarmélia Maria Noia Barreto, N Yamaguchi, F. Di Silverio et al.|Journal of Thoracic Oncology|2017Cited by 0